title: Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
abstract: Fibroblast activation protein-α (FAP) is a cell surface, serine protease of the post-prolyl peptidase family that is expressed in human breast cancer but not in normal tissues. Previously, we showed that FAP expression increased tumor growth rates in a mouse model of human breast cancer. Here the role of the proteolytic activities of FAP in promoting tumor growth, matrix degradation and invasion was investigated. Mammary fat pads of female SCID mice were inoculated with breast cancer cells that express FAP and the mice treated with normal saline or Val-boroPro (talabostat); Glu-boroPro (PT-630); or 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine (LAF-237) that inhibit prolyl peptidases. Other mice were injected with breast cancer cells expressing a catalytically inactive mutant of FAP and did not receive inhibitor treatment. PT-630 and LAF-237 did not slow growth of tumors produced by any of the three cell lines expressing FAP. Talabostat slightly decreased the growth rates of the FAP-expressing tumors but because PT-630 and LAF-237 did not, the growth retardation was likely not related to the inhibition of FAP or the related post-prolyl peptidase dipeptidyl peptidase IV. Breast cancer cells expressing a catalytically inactive mutant of FAP (FAP(S624A)) also produced tumors that grew rapidly. In vitro studies revealed that cells expressing wild type FAP or FAP(S624A) degrade extracellular matrix (ECM) more extensively, accumulate higher levels of matrix metalloproteinase-9 (MMP-9) in conditioned medium, are more invasive in type I collagen gels, and have altered signaling compared to control transfectants that do not express FAP and form slow growing tumors. We conclude that the proteolytic activity of FAP participates in matrix degradation, but other functions of the protein stimulate increased tumor growth.
authors: Department of Pathology, Winthrop P. Rockefeller Cancer Institute, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA.
authors: Yan
authors: Y
authors: Huang
authors: Avis E
authors: AE
authors: Simms
authors: Anna
authors: A
authors: Mazur
authors: Sophie
authors: S
authors: Wang
authors: Noel R
authors: NR
authors: León
authors: Barry
authors: B
authors: Jones
authors: Nazneen
authors: N
authors: Aziz
authors: Thomas
authors: T
authors: Kelly
references: Nat Cell Biol. 2000 Oct;2(10):737-44
references: 11025665
references: Cancer Lett. 2003 Sep 10;199(1):91-8
references: 12963128
references: Arch Biochem Biophys. 2007 Jan 15;457(2):177-86
references: 17174263
references: Biochim Biophys Acta. 2008 Sep;1784(9):1130-45
references: 18262497
references: Cancer Res. 2004 Apr 15;64(8):2712-6
references: 15087384
references: Int J Cancer. 2000 Aug 1;87(3):336-42
references: 10897037
references: Int J Cancer. 2001 Jan 20;95(1):67-72
references: 11241314
references: Bioorg Med Chem Lett. 2009 Apr 1;19(7):1908-12
references: 19269819
references: Cancer Res. 2002 Aug 15;62(16):4767-72
references: 12183436
references: Clin Exp Metastasis. 2003;20(5):459-70
references: 14524536
references: Biochem Pharmacol. 2005 Jul 1;70(1):134-43
references: 15907807
references: Br J Haematol. 2009 Jun;145(6):775-87
references: 19388929
references: Curr Opin Chem Biol. 2003 Aug;7(4):496-504
references: 12941425
references: Clin Exp Metastasis. 1999 Feb;17(1):57-62
references: 10390148
references: Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
references: 2402505
references: Mini Rev Med Chem. 2008 Jun;8(7):719-27
references: 18537727
references: J Med Chem. 2008 Oct 9;51(19):6005-13
references: 18783201
references: Cancer Res. 1993 Jul 15;53(14):3327-35
references: 8391923
references: Clin Exp Metastasis. 1998 Aug;16(6):501-12
references: 9872598
references: Curr Top Med Chem. 2007;7(6):621-35
references: 17352682
references: Arthritis Res Ther. 2006;8(1):R23
references: 16507127
references: J Clin Invest. 2004 Sep;114(5):623-33
references: 15343380
references: Oncogene. 2004 Jul 15;23(32):5435-46
references: 15133496
references: Cancer Res. 2004 Aug 1;64(15):5471-80
references: 15289357
references: Blood. 2006 Feb 15;107(4):1397-404
references: 16223769
references: Cell. 1998 May 1;93(3):411-22
references: 9590175
references: Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):479-86
references: 19748065
references: Adv Exp Med Biol. 2003;524:235-43
references: 12675244
references: Carcinogenesis. 2002 Oct;23(10):1593-601
references: 12376466
references: Exp Cell Res. 1998 May 1;240(2):368-76
references: 9597010
references: Int J Cancer. 2009 Jan 1;124(1):27-35
references: 18823010
references: J Clin Invest. 2009 Dec;119(12):3613-25
references: 19920354
references: Cell. 1996 May 31;85(5):683-93
references: 8646777
references: Am J Pathol. 2002 Oct;161(4):1429-37
references: 12368215
references: Curr Top Dev Biol. 2003;54:207-32
references: 12696751
references: Mod Pathol. 1998 Sep;11(9):855-63
references: 9758365
references: Cancer Lett. 2005 Sep 28;227(2):229-36
references: 16196122
references: J Biol Chem. 2005 May 20;280(20):19441-4
references: 15809306
references: Br J Haematol. 1999 Feb;104(2):365-73
references: 10050721
references: Pancreas. 2008 Aug;37(2):154-8
references: 18665076
references: Mol Cancer Ther. 2005 Mar;4(3):351-60
references: 15767544
references: J Cell Biol. 2003 Mar 3;160(5):753-67
references: 12615911
references: Cancer Res. 2004 Mar 1;64(5):1675-86
references: 14996727
references: J Biol Chem. 1997 Mar 21;272(12):7595-601
references: 9065413
references: Drug Resist Updat. 2005 Feb-Apr;8(1-2):51-8
references: 15939342
references: J Cell Biol. 1992 Dec;119(5):1309-25
references: 1447304
references: Hepatology. 1999 Jun;29(6):1768-78
references: 10347120
references: Cancer Res. 1994 Nov 1;54(21):5702-10
references: 7923219
references: Clin Cancer Res. 2007 Mar 15;13(6):1736-41
references: 17363526
references: J Biol Chem. 1999 May 7;274(19):13066-76
references: 10224058
references: Hum Pathol. 2006 Mar;37(3):352-60
references: 16613331
references: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61
references: 7911242
references: J Biol Chem. 1999 Aug 27;274(35):24947-52
references: 10455171
references: Clin Cancer Res. 2003 May;9(5):1639-47
references: 12738716
references: Anticancer Res. 2003 Jul-Aug;23(4):3195-8
references: 12926053